BOSTON (AP) _ AVEO Pharmaceuticals Inc. (AVEO) on Monday reported a loss of $3.3 million in its third quarter.

On a per-share basis, the Boston-based company said it had a loss of 9 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The cancer drug company posted revenue of $30.4 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $30 million.

AVEO shares have more than tripled since the beginning of the year. In the final minutes of trading on Monday, shares hit $14.78, more than doubling in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVEO at https://www.zacks.com/ap/AVEO

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News